🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are thrilled to announce that our SVP, Finance & Operations, hsinloke, has been appointed as a #NED at the Cell and Gene Therapy Catapult. With over 25 years of experience in the life sciences industry, Hsin will bring a wealth of expertise to this NED role. ct.catapult.org.uk/news/hsin-loke…

Our Principal Scientist, Christine Oswald & Senior Scientist, Raphael Reinbold will be attending the 9th RSC BMCS / SCI – Where Science Meets Business💡 Symposium on GPCRs in Medicinal Chemistry taking place from 2nd – 4th October in Verona, Italy. Get in touch to find out more about our #GPCR programs.

We are delighted to announce three key #appointments to our development team based in the US and UK. Steve Griffen joins as VP of Clinical Development, Angela joins as Director of Clinical Operations & Stuart Hadley joins as Senior Director of CMC. omass.com/2024/10/01/oma…

Our Senior Scientists Alex Wilkinson and Dillon Popat will be delivering poster presentations at the @ELRIG_UK – Drug Discovery 2024 taking place in London from 2-3 October. To view the full programme visit: elrig.org/wp-content/upl… #ELRIG #Conference #ELRIGDD24 #DrugDiscovery

Our Senior Director of Computational Chemistry Ben Tehan will be speaking at the MGMS Computational Drug Design #Symposium on 4 October in Stevenage. Ben’s presentation, titled ‘Molecular Dynamics in a Mass Spectrometry Company’ is at 2pm BST.

A big welcome to Juliane Schwaderer who joins our team as Director of R&D Project Management. Our team continues to expand as we enter an exciting stage of development. To learn more about OMass, visit our website: omass.com #drugdiscovery #immunology #MassSpec

Our publication in nature Communications highlights the power of hydrogen deuterium exchange #HDX for studying protein dynamics showing how HDX-MS helps understand drug mechanisms and the importance of early compound property insights for developing SAR. nature.com/articles/s4146…

Our CEO Ros Deegan (she/her), CBO Melissa Faris and SVP of Finance and Operations Hsin Loke will be attending this year’s Jefferies London Healthcare #Conference taking place from 19-21 November. If you’d like to connect, please contact: [email protected]

Our CEO @RosDeegan was this year’s Women-Led Business Leader of the Year at the European Lifestars Awards! Under Ros’ leadership, we are excited to see what the next year holds! #awards #drugdiscovery #masspec #biotech #lifescience #innovation #leadership

Publication Alert 🚨 Check out Corinne Lutomski new paper in Nature Chemistry: Defining proteoform-specific interactions for drug targeting in a native cell signalling environment #MassSpec #TopDown #Native Kavli Institute for Nanoscience Discovery, Oxford The Kavli Foundation Wolfson College, Oxford nature.com/articles/s4155…

Life sciences plays an important role in our society and economy, but it often struggles to secure funding. Ahead of our 10th anniversary, we spoke to Ros Deegan, CEO of OMass Therapeutics, about their journey and the impact of investment on life sciences. #ThePowerOf10

Many thanks to Prof Carol Robinson and Dr Idlir Liko for talking to us about their entrepreneurial journey from an Oxford Chemistry lab to founding drug discovery company OMass. OMass Therapeutics Robinson Research Group Oxford University Innovation